Amundi - KARUNA THERAPEUTICS INC ownership

KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 248 filers reported holding KARUNA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.56 and the average weighting 0.9%.

Quarter-by-quarter ownership
Amundi ownership history of KARUNA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,394
-21.6%
140.0%0.00%
Q2 2023$3,053
+23.7%
140.0%0.00%
Q1 2023$2,468
-9.9%
140.0%0.00%
Q4 2022$2,739
-99.2%
14
-99.1%
0.00%
Q3 2022$351,000
+66.4%
1,6030.0%0.00%
Q2 2022$211,000
+26.3%
1,603
+31.0%
0.00%
Q1 2022$167,000
+11.3%
1,2240.0%0.00%
Q4 2021$150,000
-18.9%
1,224
-19.1%
0.00%
Q3 2021$185,000
+7.6%
1,5130.0%0.00%
Q2 2021$172,0001,5130.00%
Other shareholders
KARUNA THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Sofinnova Investments, Inc. 1,952,441$150,963,00011.19%
Eventide Asset Management 901,077$69,671,0001.36%
First Light Asset Management, LLC 128,200$9,912,0001.02%
Prosight Management, LP 15,826$1,224,0000.58%
MOODY ALDRICH PARTNERS LLC 30,970$2,395,0000.50%
PFM Health Sciences, LP 137,960$10,667,0000.49%
Rock Springs Capital Management LP 244,106$18,874,0000.48%
Atika Capital Management LLC 73,500$5,683,0000.46%
Hood River Capital Management LLC 132,400$10,237,0000.44%
CATALYST PRIVATE WEALTH, LLC 5,006$387,0000.38%
View complete list of KARUNA THERAPEUTICS INC shareholders